We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Stored Blood for Transfusion Is Practical After Heart Surgery

By LabMedica International staff writers
Posted on 01 Nov 2015
Patients often need transfusions of red blood cells to replace the blood they have lost during major surgeries, however, the question of whether stored blood is safe for heart surgery patients has had mixed answers.

Red blood cells (RBCs) or erythrocytes that transport oxygen throughout the body go through several changes while in storage, potentially decreasing their oxygen-carrying ability and until now, it has not been clear as to whether such changes affect patient outcome after receiving transfusions.

Clinical scientists at the Karolinska University Hospital (Stockholm, Sweden) identified all patients who underwent coronary artery bypass graft surgery, heart valve surgery, or both between 1997 and 2012. More...
Transfusion data were obtained from the nationwide register of blood transfusions database. Storage of RBCs was classified with discrete patient groups who had exclusively received blood stored less than 14 days, 14 to 27 days, or 28 to 42 days, and a mixed storage category for patients receiving blood of mixed age. Follow-up was completed on December 31, 2013.

Between 1997 and 2012, 47,071 patients were transfused in connection with cardiac surgery in nine Swedish hospitals. Women constituted 39.2% and the mean ±SD age was 70.0 ±9.7 years. Of these patients, 36.6% exclusively received RBCs stored less than 14 days; 26.8%, RBCs stored 14 to 27 days; 8.9%, RBCs stored 28 to 42 days; and 27.8%, RBCs of mixed age. Most clinical parameters were similar in the groups, although the less common blood groups such as AB and B, were more common with longer storage. Recipients of the freshest blood received more transfusions, 3.1 versus 2. No differences were observed for a range of comorbidities. After investigating patient outcomes, the team found that the use of stored blood units did not influence heart surgery patient outcomes.

Ulrik Sartipy, MD, PhD, the lead author of the study said, “This study is by far the largest investigation focusing on the issue of blood storage in this very sensitive patient group, and we find absolutely no hint of negative health effects associated with stored blood.” The study provides very firm reassurance that the current blood storage practices are safe. The study was published on October 20, 2015, in the Journal of the American Medical Association (JAMA).

Related Links:

Karolinska University Hospital



New
Gold Member
Hematology Analyzer
Medonic M32B
Serological Pipet Controller
PIPETBOY GENIUS
New
Laboratory Software
ArtelWare
New
Specimen Radiography System
TrueView 200 Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.